Corteva (NYSE:CTVA) Price Target Raised to $82.00 at Mizuho

Corteva (NYSE:CTVA) had its target price lifted by Mizuho from $80.00 to $82.00 in a report released on Tuesday morning, Marketbeat Ratings reports. Mizuho currently has an outperform rating on the stock.

Several other research firms also recently weighed in on CTVA. JPMorgan Chase & Co. downgraded Corteva from an “overweight” rating to a “neutral” rating and upped their price target for the stock from $75.00 to $77.00 in a research note on Thursday, February 5th. Wells Fargo & Company boosted their target price on shares of Corteva from $77.00 to $85.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Weiss Ratings restated a “hold (c-)” rating on shares of Corteva in a research report on Monday, December 29th. UBS Group downgraded shares of Corteva from a “buy” rating to a “hold” rating in a report on Monday, February 9th. Finally, The Goldman Sachs Group reissued a “buy” rating and set a $88.00 price objective on shares of Corteva in a report on Thursday, February 5th. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $82.30.

Corteva Trading Up 0.5%

Shares of Corteva stock opened at $75.40 on Tuesday. Corteva has a fifty-two week low of $53.40 and a fifty-two week high of $77.41. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The company has a market capitalization of $50.71 billion, a P/E ratio of 47.72, a P/E/G ratio of 2.56 and a beta of 0.75. The company has a fifty day moving average of $70.06 and a 200 day moving average of $68.46.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting the consensus estimate of $0.22. The business had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business’s revenue was down 1.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts anticipate that Corteva will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio is currently 45.57%.

Institutional Investors Weigh In On Corteva

Several large investors have recently added to or reduced their stakes in the stock. Activest Wealth Management boosted its holdings in shares of Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after purchasing an additional 200 shares during the period. JPL Wealth Management LLC bought a new stake in Corteva in the third quarter worth $25,000. True Wealth Design LLC lifted its position in Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after buying an additional 264 shares during the last quarter. Total Investment Management Inc. purchased a new position in Corteva during the second quarter worth $27,000. Finally, Curat Global LLC increased its position in Corteva by 93.7% during the second quarter. Curat Global LLC now owns 370 shares of the company’s stock valued at $28,000 after acquiring an additional 179 shares during the last quarter. 81.54% of the stock is owned by institutional investors.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.